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Purpose
The purpose of this quality improvement study is to compare the rate 
of depression screening, treatment, and referral to behavioral health 
in adult patients with DM2 pre- and post- integration of depression 
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Background

•  Diabetes mellitus and depression are important comorbid 
conditions that can lead to more serious health outcomes 
(Otienoet et al., 2017). 
•  The American Diabetes Association (ADA) supports routine 
screening for depression as part of standard diabetes 
management (ADA, 2017). Early detection and treatment of 
depression leads to better health care outcomes, e.g., medication 
and dietary compliance, less comorbidities, and decrease in health 
care costs.
•  The PHQ-2 screen found comparable performance with other 
instruments and  also a good diagnostic performance in screening 
for major depressive disorder (Tsoiet et al., 2017). In a systematic 
review and meta-analysis study, de Joodeet et al. (2019) evaluated 
the diagnostic accuracy of depression questionnaires in adults 
with type 1 or type 2 diabetes and found that PHQ-9 had the 
highest specificity.
•  A study by Joseph et al. (2018) confirmed that routine screening 
for depression in patients with diabetes hospitalized with a 
medical illness is easy and feasible.
•  Despite evidence-based recommendations, routine depression 
screening and management are not always included in the 
management of patients with diabetes (Joseph et al., 2018), thus 
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●  Study Duration
Period of enrollment or chart review covers those from the year 2017 or 
prior for before integration data and 2020 to present for after integration. 
●   Study Population
Inclusion criteria: Adult patients with diabetes (18 years of age and 
above) with no initial diagnosis of depression or other mental illnesses.
Exclusion criteria: Younger than the study population (<18 years of age) 
with previous diagnosis of depression or mental illness prior to diabetes 
diagnosis and taking any antidepressants or antipsychotic agents.
Comparison group: Study population of the same characteristics from 
the same clinic before integration.
●  Endpoints
Screened with PHQ2; if positive, screened with PHQ9, started on 
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●  This quality improvement study shows that there is no difference 
in the rate of depression screening, treatment, and referral to 
behavioral health in adult patients with DM2 pre- and post-
integration of depression screening tools into the EHR.
●  This suggests providers are good in screening DM2 patients for 
depression whether the screening tools were incorporated in the 
EHR or not. 
●  For consistent depression screening and reliability of 
documentation, future studies with  regard to provider-support 
staff and patient convenience relating to accessibility and 
availability of the tool should be conducted. 
●  Ease of charting, hours of work to scan documents into the EHR, 
risk of patient information getting lost, and the use of paper that 





●  All subjects (100%) were screened using PHQ-2 before integration and 
after integration. Twenty percent of patients screened had a positive PHQ2 
among subjects before integration, while 10% had a positive PHQ2 after 
integration. Twenty percent of patients were screened with a PHQ9 pre-
integration that accounted for 100% of those subjects with a positive 
PHQ2.
●  There were no referrals made to the behavior team in both groups.
●  However, of the 10% of patients with a positive PHQ2 post-integration, 
only 6.7% of subjects were screened, which means not all patients with a 
positive PHQ2 were adequately screened post-integration. Interestingly, 
10% of patients were treated with antidepressants before integration, 
while none were treated with medications in the post-integration group.
● Determine whether 
depression screening in the 
EHR has increased 
depression screening, 
treatment, and/or referral to 
behavior team by at least 
60% in 6 months after 
integration. 
● Compare the data before 
integration and after 
integration using descriptive 
statistics. 
● Develop an efficient way to 
improve consistent 
depression screening. 
